RT Book, Section A1 Dolan, Brigid A1 Walsh, Judith A2 Papadakis, Maxine A. A2 McPhee, Stephen J. A2 Rabow, Michael W. A2 McQuaid, Kenneth R. SR Print(0) ID 1193123296 T1 Sexuality & Sexual Health in Women T2 Current Medical Diagnosis & Treatment 2023 YR 2023 FD 2023 PB McGraw-Hill Education PP New York, NY SN 9781264687343 LK accessmedicine.mhmedical.com/content.aspx?aid=1193123296 RD 2024/10/13 AB Approximately 40–50% of women will experience concerns pertaining to sexual health during their lifetime. DSM-5 updated the classification of female sexual dysfunction, combining hypoactive sexual desire disorder and sexual arousal disorder into a larger category termed "female sexual interest or arousal disorder." Despite this reclassification, some groups recommend maintaining the two as separate clinical entities due to disparate pathophysiology and specific evidence supporting treatments for HSDD. Additional conditions that may impact female sexual health include female orgasmic disorder and genitopelvic pain or penetration disorder. When diagnosing any sexual health disorder, symptoms must be present for 6 months, be personally distressing to the patient, and meet at least three of six specific criteria related to symptoms and frequency (outlined in DSM-5) to ensure an accurate diagnosis. Duration criteria may limit overdiagnosis as transient factors commonly impact sexual function, such as relationship conflict or other life events.